Rex A. Speerhas, RPH Mr. Speerhas is a board-certified nutrition support pharmacist and a certified diabetes educator at the Cleveland Clinic.
S. Sethu K. Reddy, MD, FRCPC Dr. Reddy is a member of the staff of the Department of Endocrinology at the Cleveland Clinic and has research interests in the epidemiology of diabetes its risk factors, and the implementation of guidelines.
ABSTRACT
Troglitazone is the first of a new family of antihyperglycemic drugs. We review its use in clinical practice.
